As of 2025-08-15, the Relative Valuation of Albireo Pharma Inc (ALBO) is (86.29) USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.15 USD, the upside of Albireo Pharma Inc based on Relative Valuation is -295.5%.
The range of the Relative Valuation is (64.48) - (111.64) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.1x - 17.7x | 13.7x |
| Forward P/E multiples | 10.2x - 20.8x | 13.6x |
| Fair Price | (64.48) - (111.64) | (86.29) |
| Upside | -246.1% - -352.9% | -295.5% |
| Date | P/E |